RHS Financial’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$400K Buy
33,344
+16,442
+97% +$198K 0.14% 114
2026
Q2
$188K Buy
+16,902
New +$206K 0.08% 163

Other funds holding BTAL

RHS Financial's BTAL Position: Q3 2026 in Review

RHS Financial increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 97% in Q3 2026, buying an estimated $198K and bringing the position to 33,344 shares worth $400K. The position accounts for 0.14% of the portfolio, ranked #114.

RHS Financial first reported a position in BTAL in Q2 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold BTAL as of Q3 2026.

  • RHS Financial held 33,344 shares of AGF US Market Neutral Anti-Beta Fund worth $400K as of Q3 2026.
  • RHS Financial bought 16,442 AGF US Market Neutral Anti-Beta Fund shares in Q3 2026, an estimated $198K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.14% of RHS Financial's portfolio in Q3 2026, its #114 holding.
  • RHS Financial first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2026.

Based on RHS Financial's 13F filing for Q3 2026, filed 13 Oct 2026.